Depth of Invasion as a Predictor of Contralateral Nodal Metastasis in Lateralized Oral Tongue Squamous Cell Carcinomas

• by Jake Sims, Abdurrahman Abdurrob, Jun Jin, Wamidh L. AlKhoory, Khalid Shittu, Steven Chang, Samantha H. Tam, Rushil R. Dang

• October 14, 2026

2026 ASCO Breast Cancer Highlights: PANKU-Breast02

Harold Burstein, MD, PhD, and Ana C. Garrido-Castro, MD discuss new results from the PANKU-Breast02 Study on a new dual-antibody drug conjugate, called izalontamab brengitecan (iza-bren), for metastatic triple-negative breast cancer.

• October 15, 2026

• 1 min

Overall survival of Black patients with newly diagnosed multiple myeloma in the era of triplet and quadruplet therapies

• by Hamlet Gasoyan, Shahzad Raza, Michael B. Rothberg, Jeffrey D. Kovach, Nicholas J. Casacchia, Jason Valent, Faiz Anwer

• October 7, 2026

Building a Pre-Disease Data Map

Mayo Clinic and Thermo Fisher launch a large-scale multi-omics resource designed to reveal disease before symptoms appear

• October 7, 2026

• 2 min